Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.

Article

Ajinomoto Burns Through Buyback Budget Faster Than Its Share Count

Ajinomoto has used 79.58% of its ¥80bn repurchase budget but only 48.73% of its 30 million share cap, with the program set to run through November 30, 2026.

Sep 8, 20261 min readAjinomoto Co., Inc.2802
Illustration of stock certificates and a partially filled bar chart representing a company's share buyback progress against its authorized budget.

Ajinomoto Co. bought back 1,250,600 shares for ¥6.66bn in August, according to the monthly status report the company filed with the Kanto Local Finance Bureau on September 8. That brings cumulative purchases under its November 2025 board authorization to 14,618,700 shares for ¥63.67bn, equal to 48.73% of the 30 million share cap but 79.58% of the ¥80bn value cap.

The gap between those two percentages is the story. Ajinomoto has spent nearly four-fifths of its yen budget while using less than half of its share allowance, which means it has been paying a higher average price per share than the program's early pace implied. The board resolution, passed November 6, 2025, permits market purchases on the Tokyo Stock Exchange through November 30, 2026.

Ajinomoto buyback: August vs. cumulative vs. authorized
Board resolution of November 6, 2025; repurchase window runs December 1, 2025 to November 30, 2026.
MetricAugust 2026Cumulative to Aug 31, 2026Authorized cap
Shares repurchased1,250,60014,618,700 (48.73%)30,000,000
Value spent¥6.66bn¥63.67bn (79.58%)¥80bn

Separately, on August 25 Ajinomoto disposed of 751,000 treasury shares worth ¥2.97bn to continue funding its mid-term performance-linked stock compensation system for executive officers. As of August 31, the company held 24,186,685 treasury shares against 977,735,616 shares issued. This is a routine monthly progress filing under the Financial Instruments and Exchange Act, not a new buyback authorization, and it makes no claim about share-price effects.